| 注册
首页|期刊导航|检验医学与临床|HPV-DNA与液基制片法在宫颈癌前病变检测中的临床价值研究

HPV-DNA与液基制片法在宫颈癌前病变检测中的临床价值研究

闫泓霖 王登兰 李莉

检验医学与临床2016,Vol.13Issue(15):2087-2089,3.
检验医学与临床2016,Vol.13Issue(15):2087-2089,3.DOI:10.3969/j.issn.1672-9455.2016.15.006

HPV-DNA与液基制片法在宫颈癌前病变检测中的临床价值研究

Study of clinical value of HPV-DNA and thinprep cytologic test for detecting cervical precancerous lesion

闫泓霖 1王登兰 1李莉2

作者信息

  • 1. 新疆医科大学第二附属医院妇产科,乌鲁木齐830028
  • 2. 华中科技大学同济医学院附属同济医院妇产科,武汉430030
  • 折叠

摘要

Abstract

Objective To compare the clinical value of HPV‐DNA detection and thinprep cytologic test (TCT) in the diagnosis of cervical precancerous lesion .Methods A total of 200 patients with cervical lesion in the Second Affiliated Hospital of Xinjiang Medical University served as the research subjects and performed the HPV‐DNA detection and TCT for comparing their accuracy for detecting cervical precancerous lesion .Results The positive detection rate was 7 .5% for HPV‐DNA detection and 8 .5% for TCT ,the difference between them had no statistical significance (P>0 .05) .With the CIN class Ⅰ as the diagnostic standard ,the coincidence rate of HPV‐DNA detection for screening cervical precancerous lesion was 80 .0% ,which of TCT was 41 .2% ,the difference between them had statistical significance(P<0 .05) .The sensitivity and specificity of HPV‐DNA detection were higher than those of TCT .The ROC curve statistical analysis displayed that the area under the curve (AUC) of HPV‐DNA ,TCT and HPV‐DNA combined with TCT was 0 .761 ,0 .715 and 0 .867 respectively .Conclusion HPV‐DNA detection combined with TCT is the relatively sensitive and accurate method for detecting cervical precancerous lesion .

关键词

宫颈癌前病变/人乳头瘤病毒/液基细胞学/筛查

Key words

cervical precancerous lesion/human papillomavirus/liquid based cytology/screening test

引用本文复制引用

闫泓霖,王登兰,李莉..HPV-DNA与液基制片法在宫颈癌前病变检测中的临床价值研究[J].检验医学与临床,2016,13(15):2087-2089,3.

基金项目

新疆医科大学科研创新基金(XYDCX201534)。 ()

检验医学与临床

1672-9455

访问量0
|
下载量0
段落导航相关论文